Xenotransplantation: steps towards a clinical reality.
It was clear that significant research progress has been made in the two years since the last congress, although, as the chairman J.P. Soulillou (Nantes) concluded, there were no singular advances announced during the week; rather, it was a congress for assimilation of information. It was also apparent that there is now an attitude of realism in the xenotransplantation community. The prevailing mood is one of cautious optimism, to contrast with the unguarded optimism of the previous meeting. The future for clinical xenotransplantation now appears more secure than it has been previously.
Rogers
N J
NJ
Dept of Immunology, Hammersmith Campus, Imperial College of Science Technology and Medicine, London, UK.
Dorling
A
A
Moore
M
M
D000818:Animals; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D013552:Swine; D014183:Transplantation, Heterologous / Q000009:adverse effects* / Q000276:immunology* / Q000502:physiology; D014777:Virus Diseases / Q000635:transmission